Is cannabis more effective than biologics for AS? 

The debate around cannabis vs biologics for ankylosing spondylitis is growing, especially as more patients seek alternative or complementary therapies. Biologics are clinically approved for reducing inflammation and slowing disease progression, but they come with a complex side effect profile and require close monitoring. 

Cannabis, by contrast, is used off-label and lacks the same level of clinical comparison studies. However, it offers unique benefits for pain relief, sleep, and mood regulation. Some patients prefer it for its perceived natural profile, even though effectiveness data is still limited in formal medical literature. 

Comparing Cannabis and Biologics 

Mechanism of action 

Biologics target immune pathways to slow disease progression. Cannabis affects the endocannabinoid system, modulating pain and inflammation. 

Clinical validation 

Biologics are backed by large-scale trials. Cannabis still lacks broad clinical comparison studies. 

Effectiveness in symptoms 

Cannabis may offer faster relief for pain and sleep. Biologics may take weeks to reduce inflammation. 

Side effects 

Biologics can cause infections or immune reactions. Cannabis may cause dry mouth, dizziness, or temporary anxiety. 

Visit providers like LeafEase for guidance on whether cannabis vs biologics or a combined approach aligns best with your treatment goals. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Ankylosing Spondylitis and medical cannabis.